**Core Concept**
Antifibrinolytic drugs are a class of medications that inhibit the breakdown of fibrin clots, thereby preventing excessive bleeding. These drugs act by inhibiting the activity of plasmin, a proteolytic enzyme responsible for fibrinolysis.

**Why the Correct Answer is Right**
The correct answer is a drug that specifically targets plasmin or the fibrinolytic pathway. Aprotinin is a serine protease inhibitor that inhibits the activity of plasmin, kallikrein, and other enzymes involved in fibrinolysis, making it an effective antifibrinolytic agent. Aprotinin works by binding to the active site of these enzymes, thereby preventing them from breaking down fibrin clots.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it does not inhibit fibrinolysis. Instead, it is an anticoagulant that prevents the formation of new clots.
* **Option B:** This option is incorrect because it is an antiplatelet agent that inhibits platelet aggregation, but does not affect fibrinolysis.
* **Option C:** This option is incorrect because it is a fibrinolytic agent that enhances the breakdown of fibrin clots, rather than inhibiting it.

**Clinical Pearl / High-Yield Fact**
Aprotinin is a high-risk medication that requires careful monitoring and dosing to prevent adverse effects, including anaphylaxis and renal dysfunction.

**Correct Answer:** C. Aprotinin